Reagents

Active Awarded Last action

Contract number
HT001426FE086
Awardee
Awarding agency
Obligated
$18,528

Award facts

Contract value 100% obligated
$18,528.00 Current and potential, with all options
Completion date 26% complete
Current and potential, with all options
Contracting staff
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6515 Medical And Surgical Instruments, Equipment, And Supplies
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20889, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency issued a BPA call to Becton, Dickinson And Company, doing business as BD Biosciences, for reagents with a ceiling of $18,528.00 on August 4, 2026. The call is firm fixed price, with no set-aside used. Performance is in Bethesda, Maryland 20889, through August 3, 2027. The awardee is a large for-profit medical technology manufacturer.

Quick answers

Who was awarded contract HT001426FE086?

HT001426FE086 was awarded to Becton, Dickinson And Company by Defense Health Agency (Department of Defense) on August 4, 2026.

How much is contract HT001426FE086 worth?

The government has obligated $18,528 on HT001426FE086.

Is contract HT001426FE086 an order under another contract?

Yes. HT001426FE086 is a BPA call under HT001425AE005, a blanket purchase agreement.

Was contract HT001426FE086 competed?

The extent of competition for HT001426FE086 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award